This is early beta for now! Can't handle all templates properly
Hankkija
Vastaanotettu Hilmaan | 2019-12-31 |
Ilmoituksen numero | 2019-012982 |
TED numero | 2019/S 112-274804 |
Ostajaorganisaatio | National Institute for Health and Welfare (2229500-6 ) PL 30 FI-00271 Helsinki https://thl.fi/en/web/thlfi-en |
Hankinnan otsikkotiedot | Tick-borne Encephalitis (TBE) Vaccine |
Hankinnan yhteenlaskettu kokonaisarvo koko ajalle (ilman alv:ta) arvio | |
Hankinnan yhteenlaskettu kokonaisarvo koko ajalle (ilman alv:ta) lopullinen | 1 208 950 EUR |
Alkuperäinen ilmoitus | https://www.hankintailmoitukset.fi/en/public/procurement/20806/notice/24565/overview |
Originaali JSON tietue | 24565.json |
Ostettava
Hankinnan lyhyt kuvaus | The purpose of STM and the Customer is to procure Tick-Borne Encephalitis (TBE) vaccines for adults and children. The number of doses and amounts to be delivered as well as the delivery timetable, are set out in Annex 1 Description of the Procurement The Customer will implement the procurement on STM´s side. The roles of STM and Customer are described in more detail in Annex 1 Description of the Procurement. The subject of procurement and the mandatory requirements relating to it are described in detail in this Invitation to Tender and its annexes. Partial tenders will not be considered. Alternative tenders will not be considered. The contract will be awarded to one Supplier based on a comparison of tenders. CONTRACT PERIOD September 2018 – February 2021 OPTION If the Customer decides to exercise the option, the tenderer is committed to the following extensions of the contract: March 2021 - March 2022 |
Hankintanimikkeistö (CPV) pää | |
Hankintanimikkeistö (CPV) muut | |
Aluekoodi | FI |
Pääasiallinen suorituspaikka |
Sopimukset
Päätös päivämäärä | 2018-10-08 |
Sopimusnumero | |
Myyjät | GlaxoSmithKline Oy (FI), 0108378-4 |